A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients

Journal of Clinical Psychiatry

Volumn 70, Issue 4, 2009, Pages 477-486

  Gleeson, John F M ^a,c   Cotton, Sue M ^b   Alvarez Jimenez, Mario ^b,d   Wade, Darryl ^e   Gee, Donna ^e   Crisp, Kingsley ^e   Pearce, Tracey ^e   Newman, Belinda ^b   Spiliotacopoulos, Daniela ^b   Castle, David ^a,f   McGorry, Patrick D ^b,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NorthWestern Mental Health   (Australia)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^f St Vincenta's Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAMILY THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHIATRIC TREATMENT; PSYCHOSIS; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 66349121079     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04407     Document Type: Article

References (46)

1. Robinson DG, Woerner MG, Delman HM, et al. Pharmacological treatments for first-episode schizophrenia. Schizophr Bull 2005;31:705-722 (Pubitemid 41253320)
2. Schooler N, Rabinowitz J, Davidson M, et al. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry 2005;162:947-953 (Pubitemid 40676208)
3. Emsley R, Rabinowitz J, Medori R. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res 2007;89:129-139 (Pubitemid 44881311)
4. Lieberman JA, Tollefson G, Tohen M, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry 2003;160:1396-1404 (Pubitemid 41070913)
5. Wiersma D, Nienhuis FJ, Slooff CJ, et al. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 1998;24:75-85 (Pubitemid 28128490)
6. Perlick DA, Rosenheck RA, Kaczynski R, et al. Components and correlates of family burden in schizophrenia. Psychiatr Serv 2006;57:1117-1125 (Pubitemid 44204904)
7. Penn DL, Waldheter EJ, Perkins DO, et al. Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry 2005;162:2220-2232 (Pubitemid 41740199)
8. Almond S, Knapp M, Francois C, et al. Relapse in schizophrenia: costs, clinical outcomes, and quality of life. Br J Psychiatry 2004;184:346-351 (Pubitemid 38491171)
9. Hogarty GE, Greenwald D, Ulrich RF, et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, pt 2: effects of adjustment of patients. Am J Psychiatry 1997;154:1514-1524 (Pubitemid 27471343)
10. Pilling S, Bebbington P, Kuipers E, et al. Psychological treatments in schizophrenia, pt 2: meta-analyses of randomized controlled trials of social skills training and cognitive remediation. Psychol Med 2002;32(5):783-791 (Pubitemid 34823331)
11. Gumley A, O'Grady M, McNay L, et al. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med 2003;33:419-431 (Pubitemid 36442785)
12. Linszen DH, Dingemans P, Lenior M. Early intervention and a five year follow-up in young adults with a short duration of untreated psychosis: ethical implications. Schizophr Res 2001;51(1):55-61 (Pubitemid 32722069)
13. International Early Psychosis Association Writing Group. International clinical practice guidelines for early psychosis. Br J Psychiatry Suppl 2005 Aug;48:S120-S124 (Pubitemid 41139678)
14. Craig TK, Garety P, Power P, et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 2004;329(7474):1067 (Pubitemid 39490685)
15. Goldberg K, Norman R, Hoch J, et al. Impact of a specialized early intervention service for psychotic disorders on patient characteristics, service use, and hospital costs in a defined catchment area. Can J Psychiatry 2006;51:895-903 (Pubitemid 46354053)
16. McGorry P. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the Treatment of Schizophrenia and Related Disorders. Aust N Z J Psychiatry 2005;39:1-30 (Pubitemid 40282556)
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
18. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 1986;12:578-593
19. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
20. Early Psychosis Prevention and Intervention Centre. Case Management in Early Psychosis: A Handbook. EPPIC: Parkville, Victoria, Australia: 2001
21. Edwards J, Hinton M, Elkins K, et al. Cannabis abuse and first-episode psychosis. In: Graham HL, Copello A, Birchwood M, et al, eds. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. Chichester, England: Wiley; 2003
22. Jackson H, McGorry P, Henry L, et al. Cognitively oriented psychotherapy for early psychosis (COPE): a 1-year follow-up. Br J Clin Psychol 2001;40:57-70 (Pubitemid 32293613)
23. Gilbert M, Miller K, Berk L, et al. Scope for psychosocial treatments in psychosis: an overview of collaborative therapy. Australasian Psychiatry 2003;11:220-224 (Pubitemid 36805739)
24. Ryle A, Kerr IB. Introducing Cognitive Analytic Therapy: Principles and Practice. Chichester, England: Wiley; 2002
25. Birchwood M, Smith J, Macmillan F, et al. Predicting relapse in schizophrenia: the development of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychol Med 1989;19:649-656 (Pubitemid 19243711)
26. Falloon IR. Handbook of Behavioral Family Therapy. New York, NY: Guilford Press; 1988
27. Mueser KT, Glynn SM. Behavioral Family Therapy for Psychiatric Disorders. 2nd ed. Oakland, Calif: New Harbinger; 1999
28. Linszen DH, Dingemans P, Van Der Does JW, et al. Treatment, expressed emotion, and relapse in recent onset schizophrenic disorders. Psychol Med 1996;26:333-342 (Pubitemid 26075206)
29. Alvarez-Jimenez M, Wade D, Cotton S, et al. Enhancing treatment fidelity in psychotherapy research: novel approach to measure the components of cognitive-behavioural therapy for relapse prevention in first-episode psychosis. Aust N Z J Psychiatry 2008;42:1013-1020
30. Ventura J, Liberman RP, Green MF, et al. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 1998;79:163-173 (Pubitemid 28308489)
31. First MB, Spitzer RL, Williams JBW, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) User's Guide and Interview. Washington, DC: American Psychiatric Press; 1997
32. Montgomery SM. Depressive symptoms in acute schizophrenia. Prog Neuropsychopharmacol 1979;3:429-433 (Pubitemid 10158397)
33. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, Ia: University of Iowa; 1983
34. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000;42:241-247 (Pubitemid 30216535)
35. Ginsberg JP. Wechsler Test of Adult Reading [book and test reviews]. Applied Neuropsychol 2003;10:182-184
36. Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982;8:470-484 (Pubitemid 13233541)
37. Goldman HH, Skodol AE, Lave TR. Revising Axis-V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149:1148-1156
38. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998;28(3):551-558 (Pubitemid 28241288)
39. Ali R, Awwad E, Babor T, et al. The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST): development, reliability, and feasibility. Addiction 2002;97:1183-1194
40. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption, pt 2. Addiction 1993;88:791-804 (Pubitemid 23194530)
41. Drake RE, Osher FC, Noordsy DL, et al. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57-67 (Pubitemid 20110375)
42. Nuechterlein KH, Dawson ME, Gitlin M, et al. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 1992;18:387-425
43. Ventura J, Nuechterlein KH, Hardesty JP, et al. Life events and schizophrenic relapse after withdrawal of medication. Br J Psychiatry 1992;161:615-620
44. Little R, Rubin DB. Statistical Analysis With Missing Data. New York, NY: John Wiley & Sons; 1987
45. McGorry PD, Edwards J, Mihalopoulos C, et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-326 (Pubitemid 26174576)
46. McGorry PD. Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 2007;164:859-860 (Pubitemid 46972899)